rs4646310
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006440.5(TXNRD2):c.103+418C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.144 in 152,190 control chromosomes in the GnomAD database, including 1,906 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1906 hom., cov: 32)
Consequence
TXNRD2
NM_006440.5 intron
NM_006440.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.650
Publications
24 publications found
Genes affected
TXNRD2 (HGNC:18155): (thioredoxin reductase 2) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms, including a few localized in the cytosol and some lacking the C-terminal Sec residue, have been found for this gene. [provided by RefSeq, Jun 2017]
COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
COMT Gene-Disease associations (from GenCC):
- paroxysmal dyskinesiaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TXNRD2 | NM_006440.5 | c.103+418C>T | intron_variant | Intron 1 of 17 | ENST00000400521.7 | NP_006431.2 | ||
| TXNRD2 | NM_001352300.2 | c.103+418C>T | intron_variant | Intron 1 of 16 | NP_001339229.1 | |||
| TXNRD2 | NM_001282512.3 | c.103+418C>T | intron_variant | Intron 1 of 11 | NP_001269441.1 | |||
| TXNRD2 | NR_147957.2 | n.118+418C>T | intron_variant | Intron 1 of 16 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.144 AC: 21966AN: 152072Hom.: 1907 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21966
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.144 AC: 21971AN: 152190Hom.: 1906 Cov.: 32 AF XY: 0.141 AC XY: 10510AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
21971
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
10510
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
3103
AN:
41530
American (AMR)
AF:
AC:
2203
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
726
AN:
3462
East Asian (EAS)
AF:
AC:
159
AN:
5174
South Asian (SAS)
AF:
AC:
600
AN:
4824
European-Finnish (FIN)
AF:
AC:
1586
AN:
10606
Middle Eastern (MID)
AF:
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12933
AN:
67988
Other (OTH)
AF:
AC:
348
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
936
1871
2807
3742
4678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
217
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.